Hem › Major depression › Arkansas › Little Rock
Kliniska studier för Major depression i Little Rock, AR
14 studier för Major depression söker deltagare vid platser i och runt Little Rock (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
RekryterarFas 3
- Preferred Research Partners, Inc., Little Rock
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
RekryterarFas 3
- SanRo Clinical Research Group LLC WCG Clinical Network, Bryant · 15 mi bort
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
RekryterarFas 3
- SanRo Clinical Research Group LLC WCG Clinical Network, Bryant · 15 mi bort
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
RekryterarFas 3
- Vanda Investigational Site, Little Rock
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
RekryterarFas 4
- Neurocrine Clinical Site, Bryant · 15 mi bort
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
RekryterarFas 3
- SanRo Clinical Research Group, Bryant · 15 mi bort
A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
RekryterarFas 2
- Draig Clinical Site, Little Rock
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
RekryterarFas 2
- Draig Clinical Site, Little Rock
NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
RekryterarFas 3
- Neurocrine Clinical Site, Bryant · 15 mi bort
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
RekryterarFas 3
- Woodland International Research Group, Little Rock
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
RekryterarFas 3
- Neurocrine Clinical Site, Little Rock
- Neurocrine Clinical Site, Bryant · 15 mi bort
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
RekryterarFas 2
- Preferred Research Partners /ID# 279206, Little Rock
- Woodland International Research Group /ID# 277605, Little Rock
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
RekryterarFas 2
- Pillar Clinical Research, LLC, Little Rock
- Preferred Research Partners, Inc., Little Rock
Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
RekryterarFas 3
- Neurocrine Clinical Site, Little Rock
Major depression-studier i andra städer
- New York City, NY36 studier
- Boston, MA31 studier
- Atlanta, GA25 studier
- Philadelphia, PA23 studier
- Orlando, FL19 studier
- Miami, FL18 studier
- Chicago, IL17 studier
- Tampa, FL17 studier
- San Diego, CA16 studier
- Houston, TX16 studier
- Austin, TX13 studier
- Las Vegas, NV13 studier
Andra studier i Little Rock
- Schizofreni19 studier
- Cancer (alla typer)14 studier
- Akut myeloid leukemi13 studier
- Icke-småcellig lungcancer13 studier
- Övervikt11 studier
- Endometriecancer10 studier
- Depression10 studier
- Typ 2-diabetes10 studier
- Lungcancer9 studier
- Hjärt-kärlsjukdom9 studier
- Blåscancer9 studier
- Hjärtsvikt9 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.